Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice

Alexandra E Livanos; Thomas U Greiner; Pajau Vangay; Wimal Pathmasiri; Delisha Stewart; Susan McRitchie; Huilin Li; Jennifer Chung; Jiho Sohn; Sara Kim; Zhan Gao; Cecily Barber; Joanne Kim; Sandy Ng; Arlin B Rogers; Susan Sumner; Xue-Song Zhang; Ken Cadwell; Dan Knights; Alexander Alekseyenko; Gert Fredrik Bäckhed; Martin J Blaser

doi:10.1038/nmicrobiol.2016.140

Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice

Alexandra E Livanos, Thomas U Greiner, Pajau Vangay, Wimal Pathmasiri, Delisha Stewart, Susan McRitchie, Huilin Li, Jennifer Chung, Jiho Sohn, Sara Kim, Zhan Gao, Cecily Barber, Joanne Kim, Sandy Ng, Arlin B Rogers, Susan Sumner, Xue-Song Zhang, Ken Cadwell, Dan Knights, Alexander AlekseyenkoGert Fredrik Bäckhed, Martin J Blaser

163 Citations (Scopus)

Abstract

The early life microbiome plays important roles in host immunological and metabolic development. Because the incidence of type 1 diabetes (T1D) has been increasing substantially in recent decades, we hypothesized that early-life antibiotic use alters gut microbiota, which predisposes to disease. Using non-obese diabetic mice that are genetically susceptible to T1D, we examined the effects of exposure to either continuous low-dose antibiotics or pulsed therapeutic antibiotics (PAT) early in life, mimicking childhood exposures. We found that in mice receiving PAT, T1D incidence was significantly higher, and microbial community composition and structure differed compared with controls. In pre-diabetic male PAT mice, the intestinal lamina propria had lower Th17 and T reg proportions and intestinal SAA expression than in controls, suggesting key roles in transducing the altered microbiota signals. PAT affected microbial lipid metabolism and host cholesterol biosynthetic gene expression. These findings show that early-life antibiotic treatments alter the gut microbiota and its metabolic capacities, intestinal gene expression and T-cell populations, accelerating T1D onset in non-obese diabetic mice. ' 2016 Macmillan Publishers Limited, part of Springer Nature.

Original language	English
Article number	16140
Journal	Nature Microbiology
Volume	1
Issue number	11
Pages (from-to)	1-13
Number of pages	13
ISSN	2058-5276
DOIs	https://doi.org/10.1038/nmicrobiol.2016.140
Publication status	Published - 22 Aug 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nmicrobiol.2016.140

Cite this

Livanos, A. E., Greiner, T. U., Vangay, P., Pathmasiri, W., Stewart, D., McRitchie, S., Li, H., Chung, J., Sohn, J., Kim, S., Gao, Z., Barber, C., Kim, J., Ng, S., Rogers, A. B., Sumner, S., Zhang, X-S., Cadwell, K., Knights, D., ... Blaser, M. J. (2016). Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nature Microbiology, 1(11), 1-13. [16140]. https://doi.org/10.1038/nmicrobiol.2016.140

Livanos, AE, Greiner, TU, Vangay, P, Pathmasiri, W, Stewart, D, McRitchie, S, Li, H, Chung, J, Sohn, J, Kim, S, Gao, Z, Barber, C, Kim, J, Ng, S, Rogers, AB, Sumner, S, Zhang, X-S, Cadwell, K, Knights, D, Alekseyenko, A, Bäckhed, GF & Blaser, MJ 2016, 'Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice', Nature Microbiology, vol. 1, no. 11, 16140, pp. 1-13. https://doi.org/10.1038/nmicrobiol.2016.140

@article{7e1863b711ca4a5f81aed3cf7c766501,

title = "Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice",

abstract = "The early life microbiome plays important roles in host immunological and metabolic development. Because the incidence of type 1 diabetes (T1D) has been increasing substantially in recent decades, we hypothesized that early-life antibiotic use alters gut microbiota, which predisposes to disease. Using non-obese diabetic mice that are genetically susceptible to T1D, we examined the effects of exposure to either continuous low-dose antibiotics or pulsed therapeutic antibiotics (PAT) early in life, mimicking childhood exposures. We found that in mice receiving PAT, T1D incidence was significantly higher, and microbial community composition and structure differed compared with controls. In pre-diabetic male PAT mice, the intestinal lamina propria had lower Th17 and T reg proportions and intestinal SAA expression than in controls, suggesting key roles in transducing the altered microbiota signals. PAT affected microbial lipid metabolism and host cholesterol biosynthetic gene expression. These findings show that early-life antibiotic treatments alter the gut microbiota and its metabolic capacities, intestinal gene expression and T-cell populations, accelerating T1D onset in non-obese diabetic mice. ' 2016 Macmillan Publishers Limited, part of Springer Nature.",

author = "Livanos, {Alexandra E} and Greiner, {Thomas U} and Pajau Vangay and Wimal Pathmasiri and Delisha Stewart and Susan McRitchie and Huilin Li and Jennifer Chung and Jiho Sohn and Sara Kim and Zhan Gao and Cecily Barber and Joanne Kim and Sandy Ng and Rogers, {Arlin B} and Susan Sumner and Xue-Song Zhang and Ken Cadwell and Dan Knights and Alexander Alekseyenko and B{\"a}ckhed, {Gert Fredrik} and Blaser, {Martin J}",

year = "2016",

month = aug,

day = "22",

doi = "10.1038/nmicrobiol.2016.140",

language = "English",

volume = "1",

pages = "1--13",

journal = "Nature Microbiology",

issn = "2058-5276",

publisher = "nature publishing group",

number = "11",

}

TY - JOUR

T1 - Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice

AU - Livanos, Alexandra E

AU - Greiner, Thomas U

AU - Vangay, Pajau

AU - Pathmasiri, Wimal

AU - Stewart, Delisha

AU - McRitchie, Susan

AU - Li, Huilin

AU - Chung, Jennifer

AU - Sohn, Jiho

AU - Kim, Sara

AU - Gao, Zhan

AU - Barber, Cecily

AU - Kim, Joanne

AU - Ng, Sandy

AU - Rogers, Arlin B

AU - Sumner, Susan

AU - Zhang, Xue-Song

AU - Cadwell, Ken

AU - Knights, Dan

AU - Alekseyenko, Alexander

AU - Bäckhed, Gert Fredrik

AU - Blaser, Martin J

PY - 2016/8/22

Y1 - 2016/8/22

N2 - The early life microbiome plays important roles in host immunological and metabolic development. Because the incidence of type 1 diabetes (T1D) has been increasing substantially in recent decades, we hypothesized that early-life antibiotic use alters gut microbiota, which predisposes to disease. Using non-obese diabetic mice that are genetically susceptible to T1D, we examined the effects of exposure to either continuous low-dose antibiotics or pulsed therapeutic antibiotics (PAT) early in life, mimicking childhood exposures. We found that in mice receiving PAT, T1D incidence was significantly higher, and microbial community composition and structure differed compared with controls. In pre-diabetic male PAT mice, the intestinal lamina propria had lower Th17 and T reg proportions and intestinal SAA expression than in controls, suggesting key roles in transducing the altered microbiota signals. PAT affected microbial lipid metabolism and host cholesterol biosynthetic gene expression. These findings show that early-life antibiotic treatments alter the gut microbiota and its metabolic capacities, intestinal gene expression and T-cell populations, accelerating T1D onset in non-obese diabetic mice. ' 2016 Macmillan Publishers Limited, part of Springer Nature.

AB - The early life microbiome plays important roles in host immunological and metabolic development. Because the incidence of type 1 diabetes (T1D) has been increasing substantially in recent decades, we hypothesized that early-life antibiotic use alters gut microbiota, which predisposes to disease. Using non-obese diabetic mice that are genetically susceptible to T1D, we examined the effects of exposure to either continuous low-dose antibiotics or pulsed therapeutic antibiotics (PAT) early in life, mimicking childhood exposures. We found that in mice receiving PAT, T1D incidence was significantly higher, and microbial community composition and structure differed compared with controls. In pre-diabetic male PAT mice, the intestinal lamina propria had lower Th17 and T reg proportions and intestinal SAA expression than in controls, suggesting key roles in transducing the altered microbiota signals. PAT affected microbial lipid metabolism and host cholesterol biosynthetic gene expression. These findings show that early-life antibiotic treatments alter the gut microbiota and its metabolic capacities, intestinal gene expression and T-cell populations, accelerating T1D onset in non-obese diabetic mice. ' 2016 Macmillan Publishers Limited, part of Springer Nature.

U2 - 10.1038/nmicrobiol.2016.140

DO - 10.1038/nmicrobiol.2016.140

M3 - Journal article

C2 - 27782139

SN - 2058-5276

VL - 1

SP - 1

EP - 13

JO - Nature Microbiology

JF - Nature Microbiology

IS - 11

M1 - 16140

ER -

Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this